Twist Bioscience Corp (TWST) stock

TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 13/30237% above fair value

$111.60−2.62 (-2.29%)

Close on Nov 13, 2026Market cap $7.00BP/E –Yield –

Twist Bioscience EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Twist Bioscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Twist Bioscience's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is TWST.

Revenue growth19.2% · median 13.8%

Gross margin52.0% · median 65.8%

Operating margin-33.6% · median 19.6%

Net margin-31.7% · median 9.0%

Advertisement
300 × 250

See a number that looks wrong?